Table 2 Characteristics of the study patients in the Sb and placebo groups
Saccharomyces boulardii (n = 23) | Placebo (n = 23) | P value | RR (95% CI) | |
|---|---|---|---|---|
Treatment compliance | 0.545 | |||
80% 88% 100% | 2 2 19 | 2 0 21 | ||
Abdominal pain on day 4 | 4 | 5 | 0.500 | 1.2 (0.38–4.07) |
Abdominal pain on day 8 | 0 | 0 | 1.00 | |
Fever on day 4 | 1 | 0 | 0.500 | 1.045 (0.95–1.14) |
Fever on day 8 | 0 | 0 | 1.00 | |
Improvement according PGIC scale | ||||
< 4 days | 16 (70%) | 6 (26%) | 0.03 | 0.16 (0.04–0.55) |
> 4 days | 7 (30%) | 17 (74%) | ||
Day of improvement mean ± SD | 4 ± 1 | 5 ± 0.95 | 0.001 | |
Improvement according to patient dairy | ||||
Day 2 | 1 | 0 | ||
Day 3 | 7 | 1 | ||
Day 4 | 8 | 5 | ||
Day 5 | 5 | 12 | ||
Day 6 | 2 | 3 | ||
Day 7 | 0 | 2 |